美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
0615-8504-39	0615-8504	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20240315	N/A	ANDA	ANDA211020	NCS HealthCare of KY, LLC dba Vangard Labs	BUPROPION HYDROCHLORIDE	150 mg/1	30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8504-39)
0615-8505-05	0615-8505	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20240712	N/A	ANDA	ANDA211020	NCS HealthCare of KY, LLC dba Vangard Labs	BUPROPION HYDROCHLORIDE	300 mg/1	15 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8505-05)
0615-8505-39	0615-8505	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20240315	N/A	ANDA	ANDA211020	NCS HealthCare of KY, LLC dba Vangard Labs	BUPROPION HYDROCHLORIDE	300 mg/1	30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8505-39)
16571-862-10	16571-862	HUMAN PRESCRIPTION DRUG	bupropion hydrochloride	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20220801	N/A	ANDA	ANDA211020	Rising Pharma Holdings, Inc.	BUPROPION HYDROCHLORIDE	150 mg/1	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-10)
16571-862-12	16571-862	HUMAN PRESCRIPTION DRUG	bupropion hydrochloride	bupropion hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20240603	N/A	ANDA	ANDA211020	Rising Pharma Holdings, Inc.	BUPROPION HYDROCHLORIDE	150 mg/1	120 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-12)
0615-8504-05	0615-8504	HUMAN PRESCRIPTION DRUG	Bupropion Hydrochloride	Bupropion Hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20240716	N/A	ANDA	ANDA211020	NCS HealthCare of KY, LLC dba Vangard Labs	BUPROPION HYDROCHLORIDE	150 mg/1	15 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8504-05)